Why is Thyrocare Tech. falling/rising?

As of 18-Jul, Thyrocare Technologies Ltd is experiencing a price increase, currently at Rs 1,182.60, reflecting a rise of Rs 23.15 or 2.0%. The stock has shown strong performance, with a 10.01% increase over the past week and a remarkable 82.78% rise over the last year, significantly outperforming the Sensex, which has only gained 0.51% in the same period. Today's trading saw the stock touch an intraday high of Rs 1,201.85, and it remains close to its 52-week high, just 2.31% away. Despite a recent decline in investor participation, as indicated by a 28.88% drop in delivery volume, the stock is trading above all its key moving averages, suggesting a positive momentum. The company's strong management efficiency, high return on equity, and consistent positive quarterly results contribute to its favorable outlook, although concerns about long-term growth and high promoter share pledges could pose risks.
In the broader market context, Thyrocare Technologies Ltd's recent performance stands in stark contrast to the Sensex, which has seen a decline of 0.90% over the past week. The stock's ability to generate substantial returns, particularly a 19.14% increase over the last month, indicates robust investor confidence, especially in light of its market-beating performance over both the short and long term. However, the stock's high valuation relative to its peers and the pledge of 100% of promoter shares may introduce volatility, particularly in a declining market. Overall, while the stock is currently rising, these underlying risks warrant careful consideration by investors.